Biotech Startups

Pharmaron is a contract research and manufacturing organization providing drug development and manufacturing services to pharmaceutical and biotech companies.

3 investors

PharmEnable applies AI to small molecule drug discovery, focusing on challenging and data-sparse biological targets that traditional methods struggle to address. The company develops first- and best-in-class therapies and originated as a spin-out from the University of Cambridge.

3 investors

PharOS develops and markets generic and value-added pharmaceutical products for distribution to more than 115 countries. The company employs scientists, biologists, chemists, and pharmacists focused on drug development with emphasis on customer service and product lifecycle extension.

3 investors

Pharosyn uses AI to continuously monitor clinical trials, regulatory filings, press releases, and earnings calls, and produce strategic competitive intelligence reports on a company's competitors. It serves competitive intelligence teams at pharmaceutical and biotech organizations.

3 investors

Phase Biolabs develops biotechnology to convert CO2 into ethanol and other chemicals for use in manufacturing, transportation fuels, and other industrial applications. The company uses biological processes to make carbon recycling economically viable at scale.

3 investors

Phase Genomics develops long-range genome sequencing technology based on proximity ligation, along with computational tools, for scientists studying cancer, inherited diseases, microbiomes, and biodiversity. It serves academic and research institutions and biopharmaceutical firms across life sciences, medicine, and agriculture.

3 investors

PhaseBio is a company focused on developing treatments for cardiovascular disease, which is a leading cause of death in the United States.

3 investors

PhaseV provides AI/ML-driven software for designing and optimizing clinical trials, including trial simulation, adaptive design, patient subgroup identification, and early endpoint detection. It serves biopharma sponsors and contract research organizations (CROs) in the clinical development and drug trial industry.

3 investors

Pheno Therapeutics is a clinical-stage biotech company developing GPR17 antagonists that target oligodendrocytes to promote brain repair. Its therapeutics address neurodegenerative and demyelinating disorders such as multiple sclerosis, Alzheimer's disease, ALS, Parkinson's disease, and rare leukodystrophies.

3 investors

Photys Therapeutics develops bifunctional small-molecule medicines that use induced proximity to recruit kinases and drive targeted protein phosphorylation, aiming to modulate and repair disease-driving proteins. It is building a therapeutic pipeline for autoimmune, inflammatory, oncology, and cardiometabolic diseases.

3 investors

Phycus Bio produces Purolic Acid™, a biobased glycolic acid made through fermentation using renewable, FSC-certified wood feedstock for cosmetic, personal care, adhesive, coating, and polymer applications. The company aims to replace petrochemical-derived glycolic acid with a sustainable alternative that reduces greenhouse gas emissions and eliminates formaldehyde impurities.

3 investors

Phytolon produces natural food colors derived from baker's yeast fermentation technology, offering vivid hues with heat stability and clean label credentials for food manufacturers. The company targets food producers seeking sustainable, cost-effective color solutions across multiple product categories.

3 investors

Phyx44 designs novel proteins engineered for food applications using precision fermentation and protein engineering, serving food manufacturers seeking specific taste, texture, and nutritional functionality. The company produces animal-free proteins through scalable fermentation processes.

3 investors

Pi Health develops software and AI tools to make clinical research more inclusive, efficient, and globally scalable by eliminating barriers in clinical trial recruitment and execution for pharmaceutical and biotech companies.

3 investors

Pili manufactures biosourced and decarbonized industrial dyes and pigments for textiles, inks, polymers, paints, and coatings using hybrid fermentation and organic chemistry processes. The company aims to replace fossil fuel-derived colors with sustainable, high-performance alternatives, starting with indigo for the denim industry.

3 investors

Pinnacle Medicines develops oral peptide-based therapies designed to deliver antibody-like efficacy in pill form for patients with chronic diseases. The company focuses on oral drug formulation in the biotech and pharmaceutical space.

3 investors

Moonwalk Biosciences is a life sciences company operating in the biotech sector. This page profiles a member of its leadership team.

3 investors

PL BioScience develops human platelet-based cell culture media that promote cell growth, used in biotechnology research and cell culture applications. The company was founded in 2015 in the environment of RWTH Aachen University.

3 investors

Planetarians develops food technology to produce affordable meat alternatives, drawing on protein chemistry and process engineering to bring products to market. The company operates in the foodtech and alternative protein space.

3 investors

Plex Research develops AI based on search engine algorithms to help biopharmaceutical companies analyze data for drug discovery and scientific research. It serves pharmaceutical and biotechnology companies working to turn data into better medicines.

3 investors

Polaris Genomics is a Veteran-owned biotech startup mapping molecular biomarkers to develop objective, biologically-based diagnostics and novel therapeutics for mental health and neuropsychiatric conditions such as PTSD. It combines genomics and AI to advance precision mental health care.

3 investors

Polopo develops potatoes engineered to naturally produce more protein, using a patented method applicable to any potato variety. The high-protein potatoes are grown conventionally and processed into potato chips with three times more protein, aimed at brands making better-for-you snacks.

3 investors

PolyModelsHub builds digital twins, mechanistic models, and AI-powered software workflows for biopharma R&D, development, and manufacturing. Its solutions connect modeling, data, and teams to support process development and decision-making across the biopharma value chain.

3 investors

Polyphron is using AI and automation to produce human tissue at scale, providing ground-truth data for AI biology and developing therapeutics based on immune-compatible iPSC-derived grafts.

3 investors